Connect

Partner News

Partner News

DHHS Funding Opportunities

FUNDING OPPORTUNITIES from the Department of Health and Human Services (DHHS)

____________________________________________________

Department of Health and Human Services – Centers for Disease Control – OSTLTS

National Initiative to Address COVID-19 Health Disparities among Populations at High-Risk and Underserved, Including Racial and Ethnic Minority Populations and Rural Communities

Proposal Due Date: May 3, 2021

Expected Number of Awards: 108

Estimated Total Program Funding: $2,250,000,000

Award Ceiling: $50,000,000

Award Floor: $500,000

Funding Opportunity Number: CDC-RFA-OT21-2103

Purpose: The Consolidated Appropriations Act, 2021 (P.L. 116-260), which contained the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260, Section 2, Division M) provided, in part, funding for strategies to improve testing capabilities and other COVID-19 response purposes in populations at high-risk and underserved, including racial and ethnic minority groups and people living in rural communities. Strategies also include those to develop or identify best practices for states and public health officials to use for contact tracing. To achieve these purposes, the Centers for Disease Control and Prevention (CDC) is announcing a non-competitive grant CDC-RFA-OT21-2103 titled “National Initiative to Address COVID-19 Health Disparities Among Populations at High-Risk and Underserved, Including Racial and Ethnic Minority Populations and Rural Communities.” This grant will provide funding to state, local, US territorial and freely associated state health departments (or their bona fide agents) to address COVID-19-related health disparities and advance health equity by expanding state, local, US territorial and freely associated state health departments capacity and services to prevent and control COVID-19 infection (or transmission).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332034

____________________________________________________

Department of Health and Human Services – Centers for Disease Control – National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers

Proposal Due Date: May 14, 2021

Expected Number of Awards: 2

Estimated Total Program Funding: $2,750,000

Award Ceiling:

Award Floor:

Funding Opportunity Number: CDC-RFA-PS21-2105

Purpose: This Notice of Funding Opportunity (NOFO) will address the need for conducting viral hepatitis testing of populations most affected by chronic hepatitis B and/or chronic hepatitis C and linking patients as appropriate to care and treatment, thereby reducing morbidity and mortality. This will be achieved through two completely separate components, Part A: Community Education and Awareness and Capacity Building and Part B: Professional Education/Training. Part A strategies and activities focus on leading and growing an existing national coalition that serves populations or geographic areas with high rates of viral hepatitis. The national coalition will (1) share strategies, materials, and lessons learned; (2) provide technical assistance to conduct culturally competent educational outreach; (3) build capacity to test the target populations; and (4) engage members in implementing CDC’s educational campaign(s). Outcomes for Part A are: (1) increased number and capacity of coalition members to deliver culturally competent educational outreach; (2) increased awareness among people living with chronic hepatitis B and/or chronic hepatitis C of their infection; and (3) increased exposure to CDC’s education campaign(s). Part B activities are: developing free, accurate, up-to-date, Continuing Education-accredited comprehensive web-based, on-demand hepatitis materials, resources, and trainings for health professionals. The outcomes for part B are increasing the knowledge and skills of health professionals, including the ability to screen, diagnose, medically manage, and provide care to people with chronic viral hepatitis.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=329608

____________________________________________________

Department of Health and Human Services – Centers for Disease Control- NCEH- Radiation Health Protection Involving Ionizing and Non-Ionizing Radiation

Proposal Due Date: May 15, 2021

Expected Number of Awards: 1

Estimated Total Program Funding: $1,500,000

Award Ceiling: $300,000

Award Floor: $150,000

Funding Opportunity Number: CDC-RFA-EH21-2103

Purpose: The purpose of this NOFO is to improve the understanding of radiation science to better protect the American public, workers and emergency responders from exposure to radiation from natural, environmental, medical and occupational sources as well as nuclear disasters.  The results of this work will help improve the understanding of radiation science by the radiation protection community and will assist in making public health decisions by federal, state and local public health agencies.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=329587

____________________________________________________

Department of Health and Human Services – Food and Drug Administration – SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed

Proposal Due Date: May 24, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $450,000

Award Floor: $50,000

Funding Opportunity Number: RFA-FD-21-25

Purpose: The purpose of this funding opportunity announcement is to provide support for developing and maintaining an organizational infrastructure to support a broad-based public-private partnership under FDA’s Pediatric Anesthesia Safety Initiative (PASI). Specific projects under the PASI may also be funded.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332167

____________________________________________________

Department of Health and Human Services – Food and Drug Administration – Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01 clinical trials not allowed)

Proposal Due Date: May 24, 2021

Expected Number of Awards: 1

Estimated Total Program Funding:

Award Ceiling: $600,000

Award Floor: $50,000

Funding Opportunity Number: RFA-FD-21-026

Purpose: The purpose of this funding opportunity announcement is to provide support for developing and maintaining an organizational infrastructure to support a broad-based public-private partnership under FDA’s Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Initiative. Specific projects under the ACTTION Initiative may also be funded.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332170

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Medical Scientists Training Program (T32)

Proposal Due Date: May 25, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-189

Purpose: The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained physician-scientist leaders available to meet the needs of the Nations biomedical research agenda. Specifically, this funding opportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-based approaches to integrated dual-degree training leading to the award of both professional medical doctorate degrees and research doctorate degrees (Ph.D. or equivalent). With the dual qualification of rigorous scientific research and clinical practice, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are the iterative optimization of MSTP training efficacy and efficiency, fostering the persistence of MSTP alumni in research careers, and enhancing the diversity of the physician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332110

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Short Courses on Innovative Methodologies Approaches in the Behavioral and Social Sciences (R25 – Independent Clinical Trial Not Allowed)

Letter of Intent Due Date: May 4, 2021

Proposal Due Date: June 4, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $200,000

Award Floor:

Funding Opportunity Number: RFA-OD-21-005

Purpose: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this OBSSR R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. OBSSR and participating Institutes and Centers will support educational activities that develop cross-cutting methodologies and analytics that are needed to more rapidly advance behavioral and social sciences research (BSSR) and are not already well addressed by existing educational programs widely available to the research community. Methodological domains of focus include but are not limited to innovative data collection methodologies and analytic techniques, analysis and linking of big data, or needed but underused designs to advance research across the translational spectrum. Priority will be given to courses that address an important and cross-cutting educational need, that fill a gap in the field not already well addressed by other opportunities and that include a plan for increased reach and sustainability of the training both during and beyond the funding period. Over the period of support, it is expected that the course will be refined, improved, and sufficiently developed and implemented to extend beyond in-person attendance, and beyond the end of the project period (e.g. videos, slides, course materials).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332120

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)

Proposal Due Date: June 5, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-175

Purpose: A growing body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity. These findings indicate that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for the treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This Funding Opportunity Announcement (FOA) supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. Applications must use experimental designs that incorporate active manipulations to address at least one, and ideally more, of the following topics: (1) in animals or humans, determine which parameters of neural coordination, when manipulated in isolation, improve particular aspects of cognitive, affective, or social processing; (2) in animals or humans, determine how particular abnormalities at the genomic, molecular, or cellular levels affect the systems-level coordination of electrophysiological patterns during behavior; (3) determine whether in vivo, systems-level electrophysiological changes in behaving animals predict analogous electrophysiological and cognitive improvements in healthy persons or clinical populations; and (4) use biologically-realistic computational models that include systems-level aspects to understand the function and mechanisms by which oscillatory and other electrophysiological patterns unfold across the brain to impact cognitive, affective, or social processing. This FOA uses the R01 grant mechanism, whereas its companion FOA, PAR-21-176, seeks shorter, higher-risk R21 grant applications.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332217

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)

Proposal Due Date: June 5, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-176

Purpose: This R21 funding opportunity encourages projects that test, in animals and/or humans, whether modifying electrophysiological patterns can improve cognitive, affective, or social processing. This R21 has a companion R01 (TEMP-10327). The proximal goal of this FOA (and its companion R01) is to encourage investigators to test whether modifying specific patterns of coordinated neural activity in vivo can improve cognitive, social, or affective processes. These studies should be based on a rational understanding of the role of specific neural activity rhythms in, for example, the routing of information among brain regions or in improving the ability of afferent information to affect local processing via coherence of underlying oscillatory activity.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332218

____________________________________________________

Department of Health and Human Services – National Institutes of Health – The NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed)

Proposal Due Date: June 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-128

Purpose:  This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position. This FOA is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants proposing a clinical trial, a clinical trial feasibility study, or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOAs (PAR-21-XXX or PAR-21-YYY).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332135

____________________________________________________

Department of Health and Human Services – National Institutes of Health- the NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed)

Proposal Due Date: June 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-318

Purpose: This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332113

____________________________________________________

Department of Health and Human Services – National Institutes of Health – The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)

Proposal Due Date: June 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-111

Purpose: This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332114

____________________________________________________

Department of Health and Human Services – National Institutes of Health- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)

Proposal Due Date: June 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PA-21-195

Purpose: Reissue of PA-18-613. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural, academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both the intramural and extramural phases will be mentored, and the award will provide research support during the extramural phase to help awardees launch competitive, independent research programs. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (PA-18-NNN).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332150

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)

Proposal Due Date: June 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PA-21-194

Purpose: Reissue of PA-18-614. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural, academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both the intramural and extramural phases will be mentored, and the award will provide research support during the extramural phase to help awardees launch competitive, independent research programs. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA (PA-18-NNN ).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332149

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Development of Animal Models and Related Biological Materials for Research (R21 Clinical trial not allowed)

Proposal Due Date: June 16, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $200,000

Award Floor:

Funding Opportunity Number: PAR-21-167

Purpose: This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs’ (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC, will be considered not acceptable to this FOA and will be withdrawn.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332161

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)

Letter of Intent Due Date: May 17, 2021

Proposal Due Date: June 17, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-DK-20-034

Purpose: Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogeneous teams. Efforts to diversify the research workforce have taken many forms across the career spectrum, but scientists from groups who are nationally underrepresented in biomedical and behavioral research remain less successful in securing independent research funding from NIH. Therefore, additional concerted, integrated approaches to advance the career development of scientists from underrepresented groups will be essential to achieve meaningful increases in diversity within the research workforce. The goal of this program is to establish a consortium of programs providing professional development, mentoring, networking, pilot and feasibility funds, and other opportunities designed to advance the career development of post-doctoral fellows and early career faculty scholars from backgrounds nationally underrepresented in biomedical and behavioral research who intend to focus on research in nutrition, obesity, diabetes, and related conditions. The program will be administered through research institutions with substantial existing NIH funding for research within the research mission of NIDDK.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332246

____________________________________________________

Department of Health and Human Services – National Institutes of Health – The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 clinical trial optional)

Letter of Intent Due Date: May 22, 2021

Proposal Due Date: June 22, 2021

Expected Number of Awards:

Estimated Total Program Funding: $2,000,000

Award Ceiling: $500,000

Award Floor:

Funding Opportunity Number: RFA-DK-21-004

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions and organizations proposing original research aimed at the characterization of the function of neoepitopes and neoantigens in type 1 diabetes. This includes the function that post-translational modifications might have in the humoral and cell mediated autoimmune responses and overall in the etiology and pathophysiology of type 1 diabetes. Proposals that include the discovery of neoantigens or neoepitopes are within the scope of this solicitation, but should propose a plan for integrating these discoveries with the present knowledge on established epitopes and antigens (e.g. autoantibodies for insulin, GAD65, IA-2, and ZnT8). In the long-term the goals of this initiative are to facilitate the development of better tools to monitor disease progression and treatment, and potentially to facilitate the development of personalized therapeutics.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332178

____________________________________________________

Department of Health and Human Services – National Institutes of Health – High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)

Letter of Intent Due Date: May 23, 2021

Proposal Due Date: June 23, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $250,000

Award Floor:

Funding Opportunity Number: RFA-AG-22-013

Purpose: This Funding Opportunity Announcement (FOA) invites applications to develop new research and research infrastructure for life course research on aging; attract new researchers in aging; infuse a focus on health disparities into aging research; and address ongoing needs for harmonization and biomarker collection in large population panel studies, as recommended by the 2019 BSR NACA Review.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332188

____________________________________________________

Department of Health and Human Services – National Institutes of Health – High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional)

Letter of Intent Due Date: May 23, 2021

Proposal Due Date: June 23, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $250,000

Award Floor:

Funding Opportunity Number: RFA-AG-22-012

Purpose: This Funding Opportunity Announcement (FOA) invites applications to develop new research and research infrastructure via networks for behavioral and social research on Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD); attract new researchers into behavioral and social research on AD/ADRD; infuse a focus on health disparities into AD/ADRD research; and address ongoing needs for harmonization and biomarker collection in large population panel studies to support AD/ADRD research as recommended by the 2019 BSR NACA Review.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332189

____________________________________________________

Department of Health and Human Services – National Institute of Health – Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial not allowed)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: July 2, 2021

Expected Number of Awards: 4

Estimated Total Program Funding: $1,040,000

Award Ceiling: $200,000

Award Floor:

Funding Opportunity Number: RFA-AI-21-035

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious diseases, emerging infections, or immune-mediated diseases (that include allergy, autoimmunity, or immune reactions associated with transplantation henceforth referred to as “infectious or immune-mediated diseases”) research continuum and align with the research mission of NIAID. As a part of the trans-NIAID Data Science (AI-DS) program, this R21 FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods, including artificial intelligence and machine learning approaches, that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332163

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: July 2, 2021

Expected Number of Awards: 2

Estimated Total Program Funding: $1,800,000

Award Ceiling: $600,000

Award Floor:

Funding Opportunity Number: RFA-AI-21-021

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge across the immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on enhancement and/or sustaining operations and improving the user experience and availability of existing, widely adopted informatics tools and resources. This contrasts with exploratory (R21) and early-stage (U01) development efforts to generate these tools and resources that are supported by the companion FOA s.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332162

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Early Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U10 Clinical Trial Not Allowed)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: July 2, 2021

Expected Number of Awards: 3

Estimated Total Program Funding: $1,350,000

Award Ceiling: $300,000

Award Floor:

Funding Opportunity Number: RFA-AI-21-020

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge for immune-mediated and infectious diseases including disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment and vaccines across the allergy, immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications. This contrasts with exploratory (R21) and enhancement/sustainment (U24) efforts to generate these tools and resources that are supported by the companion FOA s.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332179

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed)

Proposal Due Date: July 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-172

Purpose: The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences. At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332122

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Transition to Independent Environmental Health Research Career Award (K01 Independent Basic Experimental Studies with Humans Required)

Proposal Due Date: July 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-170

Purpose: The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences. At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences. All applications submitted to this Funding Opportunity Announcement must propose basic science experimental studies involving humans, otherwise referred to in NOT-OD-18-212 as prospective basic science studies involving human participants, that fall within the NIH definition of a clinical trial and also meet the definition of basic research.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332123

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Transition to Independent Environmental Health Research Career Award (K01 Clinical Trial Required)

Proposal Due Date: July 12, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-171

Purpose: The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences. At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial a feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332112

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Research on Bat Immunology (R21 Clinical Trial Not Allowed)

Proposal Due Date: July 15, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-184

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support research to characterize cellular and molecular constituents of the bat immune system and to understand protective innate and adaptive immune mechanisms in bats.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332193

____________________________________________________

Department of Health and Human Services – National Institutes of Health – Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: September 13, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $500,000

Award Floor:

Funding Opportunity Number: RFA-AR-22-002

Purpose: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Core Centers for Clinical Research (CCCR) (P30) within its mission. The CCCRs will provide avenues to advance the methodological sciences that support clinical research within and across the NIAMS’ portfolio of diseases.

The overall goals of the CCCR are to advance prevention, diagnosis and treatment of musculoskeletal, rheumatologic, and skin diseases by developing and fostering the implementation of novel methods, metrics, and outcome measures that address critical existing and emerging clinical research needs.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332245

____________________________________________________

Department of Health and Human Services – Substance Abuse and Mental Health Services Administration – First Responders-Comprehensive Addiction and Recovery Act Grants

Proposal Due Date: May 17, 2021

Expected Number of Awards: 20

Estimated Total Program Funding: $7,900,000

Award Ceiling: $800,000

Award Floor:

Funding Opportunity Number: TI-21-009

Purpose: The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for fiscal year (FY) 2021 First Responders-Comprehensive Addiction and Recovery Act Grants (Short Title: FR-CARA). The purpose of this program is to allow first responders and members of other key community sectors to administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for emergency reversal of known or suspected opioid overdose. Recipients will train and provide resources to first responders and members of other key community sectors at the state, tribal, and local governmental levels on carrying and administering a drug or devices approved or cleared under the FD&C Act for emergency reversal of known or suspected opioid overdose. Recipients will also establish processes, protocols, mechanisms for referral to appropriate treatment and recovery support services, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=332233